Skip to main content

3 Result(s)

within Sipke T. Visser Remove this filter

and

  1. Article

    Open Access

    Pharmacological treatment of increased vascular risk and cognitive performance in middle-aged and old persons: six-year observational longitudinal study

    Lowering vascular risk is associated with a decrease in the prevalence of cardiovascular disease and dementia. However, it is still unknown whether lowering of vascular risk with pharmacological treatment pres...

    Marlise E. A. van Eersel, Sipke T. Visser, Hanneke Joosten… in BMC Neurology (2020)

    Download PDF (729 KB) View Article

  2. No Access

    Article

    Angiotensin-Converting Enzyme Inhibitor Treatment and the Development of Urinary Tract Infections: A Prescription Sequence Symmetry Analysis

    Angiotensin-converting enzyme inhibitors (ACEi) can reduce urine output, especially when treatment is first started. Since bacterial clearance from the urinary tract is dependent on urine output, it was hypoth...

    Koen B. Pouwels, Sipke T. Visser, H. Jens Bos, Eelko Hak in Drug Safety (2013)

  3. No Access

    Article

    Cost Effectiveness of Angiotensin Receptor Blocker Monotherapy in Patients with Hypertension in the Netherlands

    Health gains and related cost savings achieved by optimizing treatment in hypertensive patients is highly important. The aim of this study was to evaluate the costs and cost effectiveness of treatment with ang...

    Dr Cornelis Boersma, Adriaan A. Voors… in American Journal of Cardiovascular Drugs (2010)